ATLANTIC AMERICAN CORP AAME Financial Statement Data


2025 Q2

Submissions

Field Row 1
adsh 0001140361-25-018588
cik 8177
name ATLANTIC AMERICAN CORP
sic 6311
countryba US
stprba GA
cityba ATLANTA
zipba 30319
bas1 4370 PEACHTREE RD NE
bas2
baph 4042665500
countryma US
stprma GA
cityma ATLANTA
zipma 30319
mas1 4370 PEACHTREE ROAD
mas2
countryinc US
stprinc GA
ein 581027114
former
changed
afs 4-NON
wksi 0
fye 1231
form 10-Q
period 20250331
fy 2025
fp Q1
filed 20250513
accepted 2025-05-13 14:09:00.0
prevrpt 0
detail 1
instance ef20047559_10q_htm.xml
nciks 1
aciks

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
cik Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings.
name Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date.
sic Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business.
countryba The ISO 3166-1 country of the registrant's business address.
stprba The state or province of the registrant’s business address, if field countryba is US or CA.
cityba The city of the registrant's business address.
zipba The zip code of the registrant’s business address.
bas1 The first line of the street of the registrant’s business address.
bas2 The second line of the street of the registrant’s business address.
baph The phone number of the registrant’s business address.
countryma The ISO 3166-1 country of the registrant's mailing address.
stprma The state or province of the registrant’s mailing address, if field countryma is US or CA.
cityma The city of the registrant's mailing address.
zipma The zip code of the registrant’s mailing address.
mas1 The first line of the street of the registrant’s mailing address.
mas2 The second line of the street of the registrant’s mailing address.
countryinc The ISO 3166-1 country of incorporation for the registrant.
stprinc The state or province of incorporation for the registrant, if countryinc is US or CA.
ein Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States.
former Most recent former name of the registrant, if any.
changed Date of change from the former name, if any.
afs Filer status with the SEC at the time of submission:
1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned.
wksi Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement.
fye Fiscal Year End Date, rounded to nearest month-end.
form The submission type of the registrant’s filing.
period Balance Sheet Date, rounded to nearest month-end.
fy Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8).
fp Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year.
filed The date of the registrant’s filing with the Commission.
accepted The acceptance date and time of the registrant’s filing with the Commission.
prevrpt Previous Report – TRUE indicates that the submission information was subsequently amended.
detail TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount).
instance The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol.
nciks Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing.
aciks Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information.

Numbers

adsh ddate tag value uom qtrs version segments coreg footnote
0001140361-25-018588 20241231 Deferred Income Tax Assets Net Without Jurisdictional Netting 18118000.0000 USD 0 0001140361-25-018588
0001140361-25-018588 20250331 Additional Paid In Capital 57425000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20241231 Assets 210819000.0000 USD 0 us-gaap/2024 Business Segments= Bankers Fidelity; Consolidation Items= Operating Segments;
0001140361-25-018588 20250331 Assets 388436000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20241231 Available For Sale Debt Securities Amortized Cost Basis 236299000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20241231 Available For Sale Debt Securities Amortized Cost Basis 27721000.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Technology Sector; Financial Instrument= Corporate Debt Securities;
0001140361-25-018588 20250331 Available For Sale Debt Securities Amortized Cost Basis 193000.0000 USD 0 us-gaap/2024 Financial Instrument= Redeemable Preferred Stock;
0001140361-25-018588 20241231 Available For Sale Securities Debt Securities 212612000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure;
0001140361-25-018588 20250331 Available For Sale Securities Debt Securities 214443000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20250331 Available For Sale Securities Debt Securities 188000.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Commercial Sector; Financial Instrument= Redeemable Preferred Stock;
0001140361-25-018588 20250331 Available For Sale Securities Debt Securities 161959000.0000 USD 0 us-gaap/2024 Financial Instrument= Corporate Debt Securities;
0001140361-25-018588 20250331 Commitments And Contingencies USD 0 us-gaap/2024
0001140361-25-018588 20250331 Common Stock Par Or Stated Value Per Share 1.0000 USD 0 us-gaap/2024
0001140361-25-018588 20250331 Common Stock Shares Outstanding 20397228.0000 shares 0 us-gaap/2024
0001140361-25-018588 20241231 Debt Securities Available For Sale Allowance For Credit Loss 0.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Commercial Sector; Financial Instrument= Corporate Debt Securities;
0001140361-25-018588 20250331 Debt Securities Available For Sale Allowance For Credit Loss 0.0000 USD 0 us-gaap/2024 Financial Instrument= U S States And Political Subdivisions;
0001140361-25-018588 20250331 Depreciation Amortization And Accretion Net 77000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20240331 Dividends Common Stock 407000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001140361-25-018588 20240331 Earnings Per Share Basic -0.1000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Equity Method Investments 1238000.0000 USD 0 us-gaap/2024 Balance Sheet Location= Other Investments; Consolidated Entities= Variable Interest Entity Not Primary Beneficiary;
0001140361-25-018588 20250331 Equity Securities Fv Ni Cost 310000.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Financial Services Sector; Financial Instrument= Common Stock And Nonredeemable Preferred Stock;
0001140361-25-018588 20241231 Equity Securities Fv Ni Current And Noncurrent 1149000.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Financial Services Sector; Financial Instrument= Common Stock And Nonredeemable Preferred Stock;
0001140361-25-018588 20241231 Equity Securities Fv Ni Current And Noncurrent 7900000.0000 USD 0 us-gaap/2024 Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure;
0001140361-25-018588 20250331 Equity Securities Fv Ni Current And Noncurrent 8671000.0000 USD 0 us-gaap/2024 Financial Instrument= Equity Securities;
0001140361-25-018588 20240331 Equity Securities Fv Ni Unrealized Gain Loss -114000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20240331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 1507000.0000 USD 1 us-gaap/2024 Business Segments= American Southern; Consolidation Items= Operating Segments;
0001140361-25-018588 20250331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 685000.0000 USD 1 us-gaap/2024 Business Segments= American Southern; Consolidation Items= Operating Segments;
0001140361-25-018588 20250331 Income Loss From Equity Method Investments -155000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Increase Decrease In Accounts Payable And Accrued Liabilities -3683000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Increase Decrease In Receivables -7370000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust 33738000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20250331 Net Cash Provided By Used In Investing Activities 1059000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20240331 Net Income Loss -1998000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Other Assets 12506000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20241231 Other Investments 6616000.0000 USD 0 us-gaap/2024 Balance Sheet Location= Other Investments; Consolidated Entities= Variable Interest Entity Not Primary Beneficiary;
0001140361-25-018588 20240331 Preferred Stock Dividends Income Statement Impact 99000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Premiums Earned Net 46913000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Premiums Receivable Allowance For Doubtful Accounts 195000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20240331 Proceeds From Maturity Prepayments And Calls Of Available For Sale Fixed Maturity Securities 2857000.0000 USD 1 0001140361-25-018588
0001140361-25-018588 20240331 Proceeds From Sale Of Marketable Securities And Policy Loans 0.0000 USD 1 0001140361-25-018588
0001140361-25-018588 20250331 Real Estate Investments 38000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20240331 Reinsurance Recoverables On Paid And Unpaid Losses 20935000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20240331 Stockholders Equity 48425000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001140361-25-018588 20240331 Stockholders Equity -7408000.0000 USD 0 us-gaap/2024 Equity Components= Treasury Stock Common;
0001140361-25-018588 20241231 Assets 393428000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20250331 Revenues 50125000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Revenues 30498000.0000 USD 1 us-gaap/2024 Business Segments= Bankers Fidelity; Consolidation Items= Operating Segments;
0001140361-25-018588 20231231 Stockholders Equity -13000.0000 USD 0 us-gaap/2024 Equity Components= Deferred Compensation Share Based Payments;
0001140361-25-018588 20231231 Stockholders Equity 55000.0000 USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0001140361-25-018588 20231231 Stockholders Equity -7401000.0000 USD 0 us-gaap/2024 Equity Components= Treasury Stock Common;
0001140361-25-018588 20240331 Stockholders Equity 102803000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20241231 Stockholders Equity -2000.0000 USD 0 us-gaap/2024 Equity Components= Deferred Compensation Share Based Payments;
0001140361-25-018588 20250331 Stockholders Equity 46150000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001140361-25-018588 20241231 Accumulated Other Comprehensive Income Loss Net Of Tax -18712000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20241231 Additional Paid In Capital 57425000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20241231 Available For Sale Debt Securities Amortized Cost Basis 37876000.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Industrial Sector; Financial Instrument= Corporate Debt Securities;
0001140361-25-018588 20231231 Premiums Receivable Allowance For Doubtful Accounts 217000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20241231 Available For Sale Securities Debt Securities 59564000.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Financial Services Sector; Financial Instrument= Corporate Debt Securities;
0001140361-25-018588 20241231 Available For Sale Securities Debt Securities 212612000.0000 USD 0 us-gaap/2024 Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001140361-25-018588 20241231 Available For Sale Securities Debt Securities 212612000.0000 USD 0 us-gaap/2024 Financial Instrument= Debt Securities;
0001140361-25-018588 20250331 Available For Sale Securities Debt Securities 214443000.0000 USD 0 us-gaap/2024 Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001140361-25-018588 20250331 Available For Sale Securities Debt Securities 214443000.0000 USD 0 us-gaap/2024 Financial Instrument= Debt Securities;
0001140361-25-018588 20240331 Common Stock Dividends Per Share Declared 0.0200 USD 1 us-gaap/2024
0001140361-25-018588 20241231 Common Stock Par Or Stated Value Per Share 1.0000 USD 0 us-gaap/2024
0001140361-25-018588 20250331 Common Stock Shares Authorized 50000000.0000 shares 0 us-gaap/2024
0001140361-25-018588 20250331 Common Stock Shares Issued 22400894.0000 shares 0 us-gaap/2024
0001140361-25-018588 20241231 Debt Securities Available For Sale Allowance For Credit Loss 0.0000 USD 0 us-gaap/2024
0001140361-25-018588 20241231 Debt Securities Available For Sale Allowance For Credit Loss 0.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Financial Services Sector; Financial Instrument= Corporate Debt Securities;
0001140361-25-018588 20241231 Debt Securities Available For Sale Allowance For Credit Loss 0.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Industrial Sector; Financial Instrument= Corporate Debt Securities;
0001140361-25-018588 20250331 Debt Securities Available For Sale Allowance For Credit Loss 0.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Technology Sector; Financial Instrument= Corporate Debt Securities;
0001140361-25-018588 20250331 Debt Securities Available For Sale Allowance For Credit Loss 0.0000 USD 0 us-gaap/2024 Financial Instrument= Asset Backed Securities;
0001140361-25-018588 20240331 Deferred Policy Acquisition Cost Amortization Expense 683000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20240331 Earnings Per Share Diluted -0.1000 USD 1 us-gaap/2024
0001140361-25-018588 20241231 Equity Method Investments 1238000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20241231 Equity Method Investments 1238000.0000 USD 0 us-gaap/2024 Balance Sheet Location= Other Investments; Consolidated Entities= Variable Interest Entity Not Primary Beneficiary;
0001140361-25-018588 20241231 Equity Securities Fv Ni Cost 4633000.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Communications; Financial Instrument= Common Stock And Nonredeemable Preferred Stock;
0001140361-25-018588 20241231 Equity Securities Fv Ni Cost 306000.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Financial Services Sector; Financial Instrument= Common Stock And Nonredeemable Preferred Stock;
0001140361-25-018588 20241231 Equity Securities Fv Ni Cost 4939000.0000 USD 0 us-gaap/2024 Financial Instrument= Equity Securities;
0001140361-25-018588 20241231 Equity Securities Fv Ni Current And Noncurrent 7900000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20241231 Equity Securities Fv Ni Current And Noncurrent 7711000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001140361-25-018588 20241231 Equity Securities Fv Ni Current And Noncurrent 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001140361-25-018588 20250331 Equity Securities Fv Ni Current And Noncurrent 8671000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20250331 Equity Securities Fv Ni Current And Noncurrent 1277000.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Financial Services Sector; Financial Instrument= Common Stock And Nonredeemable Preferred Stock;
0001140361-25-018588 20250331 Equity Securities Fv Ni Current And Noncurrent 8479000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001140361-25-018588 20250331 Equity Securities Fv Ni Current And Noncurrent 8671000.0000 USD 0 us-gaap/2024 Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001140361-25-018588 20250331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 1035000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 2437000.0000 USD 1 us-gaap/2024 Business Segments= Bankers Fidelity; Consolidation Items= Operating Segments;
0001140361-25-018588 20240331 Increase Decrease In Other Operating Assets 443000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Intangible Assets Net Including Goodwill 2544000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20241231 Investments 230126000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20241231 Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust 33738000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20241231 Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust 18042000.0000 USD 0 us-gaap/2024 Longterm Debt Type= Junior Subordinated Debt; Schedule Of Equity Method Investment Equity Method Investee Name= Atlantic American Statutory Trust I;
0001140361-25-018588 20250331 Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust 15696000.0000 USD 0 us-gaap/2024 Longterm Debt Type= Junior Subordinated Debt; Schedule Of Equity Method Investment Equity Method Investee Name= Atlantic American Statutory Trust I I;
0001140361-25-018588 20241231 Liabilities 293815000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20241231 Liability For Future Policy Benefits 98464000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20250331 Net Income Loss 802000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001140361-25-018588 20240331 Net Income Loss Available To Common Stockholders Basic -2097000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax 3137000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax 2478000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20240331 Other Expenses 4057000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Other Investments 6461000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20240331 Payments To Acquire Investments 5604000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Payments To Acquire Investments 5846000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20240331 Premiums Earned Net 44552000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20231231 Stockholders Equity 22401000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001140361-25-018588 20240331 Stockholders Equity 22401000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001140361-25-018588 20250331 Stockholders Equity 102385000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20250331 Stockholders Equity 22401000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001140361-25-018588 20250331 Stockholders Equity -7412000.0000 USD 0 us-gaap/2024 Equity Components= Treasury Stock Common;
0001140361-25-018588 20250331 Allocated Share Based Compensation Expense 2000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20240331 Amortization Of Restricted Stock 5000.0000 USD 1 0001140361-25-018588 Equity Components= Deferred Compensation Share Based Payments;
0001140361-25-018588 20241231 Assets 147214000.0000 USD 0 us-gaap/2024 Business Segments= American Southern; Consolidation Items= Operating Segments;
0001140361-25-018588 20241231 Available For Sale Debt Securities Amortized Cost Basis 63769000.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Financial Services Sector; Financial Instrument= Corporate Debt Securities;
0001140361-25-018588 20241231 Available For Sale Debt Securities Amortized Cost Basis 9131000.0000 USD 0 us-gaap/2024 Financial Instrument= U S States And Political Subdivisions;
0001140361-25-018588 20250331 Available For Sale Debt Securities Amortized Cost Basis 48499000.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Commercial Sector; Financial Instrument= Corporate Debt Securities;
0001140361-25-018588 20250331 Available For Sale Debt Securities Amortized Cost Basis 193000.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Commercial Sector; Financial Instrument= Redeemable Preferred Stock;
0001140361-25-018588 20250331 Available For Sale Debt Securities Amortized Cost Basis 234993000.0000 USD 0 us-gaap/2024 Financial Instrument= Debt Securities;
0001140361-25-018588 20241231 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001140361-25-018588 20250331 Available For Sale Securities Debt Securities 34453000.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Industrial Sector; Financial Instrument= Corporate Debt Securities;
0001140361-25-018588 20250331 Available For Sale Securities Debt Securities 214443000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure;
0001140361-25-018588 20250331 Available For Sale Securities Debt Securities 188000.0000 USD 0 us-gaap/2024 Financial Instrument= Redeemable Preferred Stock;
0001140361-25-018588 20250331 Available For Sale Securities Debt Securities 7766000.0000 USD 0 us-gaap/2024 Financial Instrument= U S States And Political Subdivisions;
0001140361-25-018588 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 35903000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect 333000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20240331 Commissions And Underwriting Expenses 4507000.0000 USD 1 0001140361-25-018588 Business Segments= American Southern; Consolidation Items= Operating Segments;
0001140361-25-018588 20250331 Commissions And Underwriting Expenses 10745000.0000 USD 1 0001140361-25-018588 Business Segments= Bankers Fidelity; Consolidation Items= Operating Segments;
0001140361-25-018588 20250331 Commissions And Underwriting Expenses -3170000.0000 USD 1 0001140361-25-018588 Consolidation Items= Corporate Non Segment;
0001140361-25-018588 20241231 Commitments And Contingencies USD 0 us-gaap/2024
0001140361-25-018588 20241231 Common Stock Shares Authorized 50000000.0000 shares 0 us-gaap/2024
0001140361-25-018588 20250331 Common Stock Shares Outstanding 20397228.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001140361-25-018588 20241231 Common Stock Value 22401000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20241231 Debt Securities Available For Sale Allowance For Credit Loss 0.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Commercial Sector; Financial Instrument= Redeemable Preferred Stock;
0001140361-25-018588 20241231 Debt Securities Available For Sale Allowance For Credit Loss 0.0000 USD 0 us-gaap/2024 Financial Instrument= Asset Backed Securities;
0001140361-25-018588 20241231 Debt Securities Available For Sale Allowance For Credit Loss 0.0000 USD 0 us-gaap/2024 Financial Instrument= U S States And Political Subdivisions;
0001140361-25-018588 20250331 Debt Securities Available For Sale Allowance For Credit Loss 0.0000 USD 0 us-gaap/2024
0001140361-25-018588 20250331 Debt Securities Available For Sale Allowance For Credit Loss 0.0000 USD 0 us-gaap/2024 Financial Instrument= Debt Securities;
0001140361-25-018588 20250331 Debt Securities Available For Sale Allowance For Credit Loss 0.0000 USD 0 us-gaap/2024 Financial Instrument= U S Government Agencies Debt Securities;
0001140361-25-018588 20241231 Deferred Compensation Equity 2000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20250331 Deferred Income Tax Expense Benefit 232000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Deferred Policy Acquisition Cost Amortization Expense 149000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20241231 Equity Securities Fv Ni Current And Noncurrent 7900000.0000 USD 0 us-gaap/2024 Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001140361-25-018588 20241231 Equity Securities Fv Ni Current And Noncurrent 7900000.0000 USD 0 us-gaap/2024 Financial Instrument= Equity Securities;
0001140361-25-018588 20240331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -2726000.0000 USD 1 us-gaap/2024 Consolidation Items= Corporate Non Segment;
0001140361-25-018588 20240331 Increase Decrease In Insurance Liabilities -8600000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Increase Decrease In Other Operating Assets 461000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20240331 Increase Decrease In Receivables -9168000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust 18042000.0000 USD 0 us-gaap/2024 Longterm Debt Type= Junior Subordinated Debt; Schedule Of Equity Method Investment Equity Method Investee Name= Atlantic American Statutory Trust I;
0001140361-25-018588 20241231 Liability For Claims And Claims Adjustment Expense 93707000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20250331 Liability For Claims And Claims Adjustment Expense 98030000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20241231 Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense And Other Policyholder Funds 225106000.0000 USD 0 0001140361-25-018588
0001140361-25-018588 20250331 Net Cash Provided By Used In Financing Activities -4000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20241231 Other Assets 11828000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20240331 Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent -1966000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001140361-25-018588 20250331 Other Invested Assets Cost 7946000.0000 USD 0 0001140361-25-018588
0001140361-25-018588 20250331 Other Policyholder Funds 1538000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20240331 Policyholder Benefits And Claims Incurred Net 19112000.0000 USD 1 us-gaap/2024 Business Segments= Bankers Fidelity; Consolidation Items= Operating Segments;
0001140361-25-018588 20250331 Preferred Stock Dividends Income Statement Impact 99000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20241231 Preferred Stock Redemption Amount 5500000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20241231 Preferred Stock Shares Issued 55000.0000 shares 0 us-gaap/2024
0001140361-25-018588 20241231 Preferred Stock Value 55000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20240331 Premiums And Other Receivables Net 14696000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20241231 Premiums And Other Receivables Net 27458000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20250331 Proceeds From Lines Of Credit 0.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Proceeds From Sale Of Marketable Securities And Policy Loans 0.0000 USD 1 0001140361-25-018588
0001140361-25-018588 20240331 Provision For Loan Lease And Other Losses -6000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20241231 Real Estate Investments 38000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20250331 Reinsurance Recoverables Allowance 45000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20250331 Reinsurance Recoverables On Paid And Unpaid Losses 23829000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20241231 Available For Sale Debt Securities Amortized Cost Basis 48509000.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Commercial Sector; Financial Instrument= Corporate Debt Securities;
0001140361-25-018588 20250331 Accumulated Other Comprehensive Income Loss Net Of Tax -16234000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20240331 Allocated Share Based Compensation Expense 5000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Amortization Of Restricted Stock 2000.0000 USD 1 0001140361-25-018588 Equity Components= Deferred Compensation Share Based Payments;
0001140361-25-018588 20241231 Available For Sale Debt Securities Amortized Cost Basis 192000.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Commercial Sector; Financial Instrument= Redeemable Preferred Stock;
0001140361-25-018588 20241231 Available For Sale Securities Debt Securities 212612000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20241231 Available For Sale Securities Debt Securities 24623000.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Technology Sector; Financial Instrument= Corporate Debt Securities;
0001140361-25-018588 20250331 Available For Sale Securities Debt Securities 59343000.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Financial Services Sector; Financial Instrument= Corporate Debt Securities;
0001140361-25-018588 20240331 Benefits Losses And Expenses 49503000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20241231 Cash And Cash Equivalents At Carrying Value 35570000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20240331 Commissions And Underwriting Expenses 10346000.0000 USD 1 0001140361-25-018588 Business Segments= Bankers Fidelity; Consolidation Items= Operating Segments;
0001140361-25-018588 20250331 Commissions And Underwriting Expenses 4105000.0000 USD 1 0001140361-25-018588 Business Segments= American Southern; Consolidation Items= Operating Segments;
0001140361-25-018588 20240331 Comprehensive Income Net Of Tax -3964000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Debt Securities Available For Sale Allowance For Credit Loss 0.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Commercial Sector; Financial Instrument= Corporate Debt Securities;
0001140361-25-018588 20240331 Deferred Income Tax Expense Benefit -508000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Dividends Common Stock 407000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001140361-25-018588 20250331 Earnings Per Share Diluted 0.0300 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Equity Securities Fv Ni Current And Noncurrent 7394000.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Communications; Financial Instrument= Common Stock And Nonredeemable Preferred Stock;
0001140361-25-018588 20240331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -1287000.0000 USD 1 us-gaap/2024 Business Segments= Bankers Fidelity; Consolidation Items= Operating Segments;
0001140361-25-018588 20250331 Income Tax Expense Benefit 233000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Increase Decrease In Insurance Liabilities -4586000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Interest Expense 774000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20240331 Liability For Claims And Claims Adjustment Expense 88449000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20241231 Loans Insurance Policy 1722000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20240331 Net Cash Provided By Used In Financing Activities 993000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Net Income Loss 802000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Net Income Loss Available To Common Stockholders Basic 703000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20240331 Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent -1966000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent 2478000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent 2478000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001140361-25-018588 20250331 Other Investments 6461000.0000 USD 0 us-gaap/2024 Balance Sheet Location= Other Investments; Consolidated Entities= Variable Interest Entity Not Primary Beneficiary;
0001140361-25-018588 20241231 Other Policyholder Funds 1757000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20250331 Policyholder Benefits And Claims Incurred Net 31913000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Premiums And Other Receivables Net 19213000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20240331 Proceeds From Lines Of Credit 1000000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Proceeds From Maturity Prepayments And Calls Of Available For Sale Fixed Maturity Securities 7169000.0000 USD 1 0001140361-25-018588
0001140361-25-018588 20250331 Provision For Loan Lease And Other Losses -12000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20231231 Reinsurance Recoverables On Paid And Unpaid Losses 21103000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20241231 Retained Earnings Accumulated Deficit 45854000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20240331 Revenues 28171000.0000 USD 1 us-gaap/2024 Business Segments= Bankers Fidelity; Consolidation Items= Operating Segments;
0001140361-25-018588 20250331 Revenues 19421000.0000 USD 1 us-gaap/2024 Business Segments= American Southern; Consolidation Items= Operating Segments;
0001140361-25-018588 20250331 Shares Paid For Tax Withholding For Share Based Compensation 2530.0000 shares 1 us-gaap/2024 Equity Components= Common Stock;
0001140361-25-018588 20231231 Stockholders Equity -16121000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001140361-25-018588 20231231 Stockholders Equity 50929000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001140361-25-018588 20240331 Stockholders Equity -8000.0000 USD 0 us-gaap/2024 Equity Components= Deferred Compensation Share Based Payments;
0001140361-25-018588 20240331 Stockholders Equity 55000.0000 USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0001140361-25-018588 20241231 Stockholders Equity 55000.0000 USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0001140361-25-018588 20250331 Stockholders Equity 57425000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001140361-25-018588 20241231 Treasury Stock Common Shares 2001136.0000 shares 0 us-gaap/2024
0001140361-25-018588 20241231 Treasury Stock Common Value 7408000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20250331 Policyholder Benefits And Claims Incurred Net 17316000.0000 USD 1 us-gaap/2024 Business Segments= Bankers Fidelity; Consolidation Items= Operating Segments;
0001140361-25-018588 20241231 Available For Sale Debt Securities Amortized Cost Basis 192000.0000 USD 0 us-gaap/2024 Financial Instrument= Redeemable Preferred Stock;
0001140361-25-018588 20241231 Available For Sale Debt Securities Amortized Cost Basis 24371000.0000 USD 0 us-gaap/2024 Financial Instrument= U S Government Agencies Debt Securities;
0001140361-25-018588 20250331 Available For Sale Debt Securities Amortized Cost Basis 62775000.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Financial Services Sector; Financial Instrument= Corporate Debt Securities;
0001140361-25-018588 20250331 Available For Sale Debt Securities Amortized Cost Basis 27960000.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Technology Sector; Financial Instrument= Corporate Debt Securities;
0001140361-25-018588 20250331 Available For Sale Debt Securities Amortized Cost Basis 24187000.0000 USD 0 us-gaap/2024 Financial Instrument= U S Government Agencies Debt Securities;
0001140361-25-018588 20241231 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001140361-25-018588 20241231 Available For Sale Securities Debt Securities 22290000.0000 USD 0 us-gaap/2024 Financial Instrument= Asset Backed Securities;
0001140361-25-018588 20250331 Available For Sale Securities Debt Securities 22061000.0000 USD 0 us-gaap/2024 Financial Instrument= Asset Backed Securities;
0001140361-25-018588 20250331 Available For Sale Securities Debt Securities 22469000.0000 USD 0 us-gaap/2024 Financial Instrument= U S Government Agencies Debt Securities;
0001140361-25-018588 20240331 Commissions And Underwriting Expenses 12666000.0000 USD 1 0001140361-25-018588
0001140361-25-018588 20250331 Common Stock Dividends Per Share Declared 0.0200 USD 1 us-gaap/2024
0001140361-25-018588 20241231 Common Stock Shares Outstanding 20399758.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001140361-25-018588 20241231 Debt Securities Available For Sale Allowance For Credit Loss 0.0000 USD 0 us-gaap/2024 Financial Instrument= U S Government Agencies Debt Securities;
0001140361-25-018588 20250331 Debt Securities Available For Sale Allowance For Credit Loss 0.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Commercial Sector; Financial Instrument= Redeemable Preferred Stock;
0001140361-25-018588 20250331 Debt Securities Available For Sale Allowance For Credit Loss 0.0000 USD 0 us-gaap/2024 Financial Instrument= Redeemable Preferred Stock;
0001140361-25-018588 20250331 Accounts Payable And Accrued Liabilities Current And Noncurrent 27771000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20241231 Available For Sale Debt Securities Amortized Cost Basis 177875000.0000 USD 0 us-gaap/2024 Financial Instrument= Corporate Debt Securities;
0001140361-25-018588 20250331 Available For Sale Debt Securities Amortized Cost Basis 234993000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20241231 Available For Sale Securities Debt Securities 187000.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Commercial Sector; Financial Instrument= Redeemable Preferred Stock;
0001140361-25-018588 20241231 Available For Sale Securities Debt Securities 212612000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001140361-25-018588 20241231 Available For Sale Securities Debt Securities 212612000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001140361-25-018588 20241231 Available For Sale Securities Debt Securities 22251000.0000 USD 0 us-gaap/2024 Financial Instrument= U S Government Agencies Debt Securities;
0001140361-25-018588 20250331 Available For Sale Securities Debt Securities 43021000.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Commercial Sector; Financial Instrument= Corporate Debt Securities;
0001140361-25-018588 20250331 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001140361-25-018588 20250331 Available For Sale Securities Debt Securities 214443000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001140361-25-018588 20250331 Available For Sale Securities Debt Securities 214443000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001140361-25-018588 20250331 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001140361-25-018588 20250331 Benefits Losses And Expenses 49090000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Cash And Cash Equivalents At Carrying Value 35903000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect -7112000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20241231 Debt Securities Available For Sale Allowance For Credit Loss 0.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Technology Sector; Financial Instrument= Corporate Debt Securities;
0001140361-25-018588 20241231 Debt Securities Available For Sale Allowance For Credit Loss 0.0000 USD 0 us-gaap/2024 Financial Instrument= Corporate Debt Securities;
0001140361-25-018588 20250331 Debt Securities Available For Sale Allowance For Credit Loss 0.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Financial Services Sector; Financial Instrument= Corporate Debt Securities;
0001140361-25-018588 20250331 Debt Securities Available For Sale Allowance For Credit Loss 0.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Industrial Sector; Financial Instrument= Corporate Debt Securities;
0001140361-25-018588 20250331 Deferred Income Tax Assets Net Without Jurisdictional Netting 17227000.0000 USD 0 0001140361-25-018588
0001140361-25-018588 20250331 Deferred Policy Acquisition Costs 44693000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20250331 Dividends Preferred Stock 99000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001140361-25-018588 20250331 Equity Method Investments 1238000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20241231 Equity Securities Fv Ni Cost 4939000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20250331 Equity Securities Fv Ni Cost 4633000.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Communications; Financial Instrument= Common Stock And Nonredeemable Preferred Stock;
0001140361-25-018588 20250331 Equity Securities Fv Ni Current And Noncurrent 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001140361-25-018588 20240331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -2506000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20240331 Income Taxes Paid 0.0000 USD 1 us-gaap/2024
0001140361-25-018588 20241231 Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust 15696000.0000 USD 0 us-gaap/2024 Longterm Debt Type= Junior Subordinated Debt; Schedule Of Equity Method Investment Equity Method Investee Name= Atlantic American Statutory Trust I I;
0001140361-25-018588 20250331 Liabilities And Stockholders Equity 388436000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20240331 Net Cash Provided By Used In Investing Activities -2786000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Net Cash Provided By Used In Operating Activities -722000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20240331 Net Income Loss -1998000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001140361-25-018588 20250331 Other Income 3000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20240331 Payments To Acquire Property Plant And Equipment 39000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20240331 Policyholder Benefits And Claims Incurred Net 31925000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Policyholder Benefits And Claims Incurred Net 14597000.0000 USD 1 us-gaap/2024 Business Segments= American Southern; Consolidation Items= Operating Segments;
0001140361-25-018588 20250331 Policyholder Benefits And Claims Incurred Net 0.0000 USD 1 us-gaap/2024 Consolidation Items= Corporate Non Segment;
0001140361-25-018588 20250331 Preferred Stock Redemption Amount 5500000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20231231 Premiums And Other Receivables Net 23690000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20241231 Premiums Receivable Allowance For Doubtful Accounts 201000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20231231 Reinsurance Recoverables Allowance 61000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20241231 Reinsurance Recoverables On Paid And Unpaid Losses 22942000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20240331 Revenues 18858000.0000 USD 1 us-gaap/2024 Business Segments= American Southern; Consolidation Items= Operating Segments;
0001140361-25-018588 20250331 Revenues 206000.0000 USD 1 us-gaap/2024 Consolidation Items= Corporate Non Segment;
0001140361-25-018588 20240331 Stockholders Equity -18087000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001140361-25-018588 20241231 Stockholders Equity 99613000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20241231 Stockholders Equity 22401000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001140361-25-018588 20250331 Treasury Stock Common Shares 2003666.0000 shares 0 us-gaap/2024
0001140361-25-018588 20250331 Unearned Premiums 20916000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20241231 Deferred Policy Acquisition Costs 44842000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20250331 Equity Securities Fv Ni Cost 4943000.0000 USD 0 us-gaap/2024 Financial Instrument= Equity Securities;
0001140361-25-018588 20241231 Equity Securities Fv Ni Current And Noncurrent 7900000.0000 USD 0 us-gaap/2024 Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001140361-25-018588 20250331 Equity Securities Fv Ni Current And Noncurrent 192000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001140361-25-018588 20250331 Equity Securities Fv Ni Current And Noncurrent 8671000.0000 USD 0 us-gaap/2024 Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure; See the aforementioned information for a description of the fair value hierarchy as well as a description of levels for classes of these financial assets.
0001140361-25-018588 20240331 Increase Decrease In Accounts Payable And Accrued Liabilities -3950000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense And Other Policyholder Funds 220520000.0000 USD 0 0001140361-25-018588
0001140361-25-018588 20250331 Long Term Line Of Credit 4022000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20250331 Net Investment Income 2442000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20240331 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax -1966000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20241231 Other Investments 6616000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20250331 Payments To Acquire Property Plant And Equipment 264000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20240331 Policyholder Benefits And Claims Incurred Net 12813000.0000 USD 1 us-gaap/2024 Business Segments= American Southern; Consolidation Items= Operating Segments;
0001140361-25-018588 20250331 Preferred Stock Par Or Stated Value Per Share 1.0000 USD 0 us-gaap/2024
0001140361-25-018588 20250331 Preferred Stock Shares Authorized 4000000.0000 shares 0 us-gaap/2024
0001140361-25-018588 20241231 Preferred Stock Shares Outstanding 55000.0000 shares 0 us-gaap/2024
0001140361-25-018588 20241231 Reinsurance Recoverables Allowance 51000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20240331 Revenues -32000.0000 USD 1 us-gaap/2024 Consolidation Items= Corporate Non Segment;
0001140361-25-018588 20241231 Stockholders Equity -18712000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001140361-25-018588 20241231 Unearned Premiums 31178000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20250331 Retained Earnings Accumulated Deficit 46150000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20250331 Preferred Stock Shares Issued 55000.0000 shares 0 us-gaap/2024
0001140361-25-018588 20250331 Preferred Stock Value 55000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20241231 Accounts Payable And Accrued Liabilities Current And Noncurrent 30948000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20240331 Adjustments Related To Tax Withholding For Share Based Compensation 7000.0000 USD 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0001140361-25-018588 20241231 Assets 35395000.0000 USD 0 us-gaap/2024 Consolidation Items= Corporate Non Segment;
0001140361-25-018588 20250331 Assets 215821000.0000 USD 0 us-gaap/2024 Business Segments= Bankers Fidelity; Consolidation Items= Operating Segments;
0001140361-25-018588 20241231 Available For Sale Debt Securities Amortized Cost Basis 236299000.0000 USD 0 us-gaap/2024 Financial Instrument= Debt Securities;
0001140361-25-018588 20250331 Available For Sale Debt Securities Amortized Cost Basis 177098000.0000 USD 0 us-gaap/2024 Financial Instrument= Corporate Debt Securities;
0001140361-25-018588 20250331 Available For Sale Debt Securities Amortized Cost Basis 9129000.0000 USD 0 us-gaap/2024 Financial Instrument= U S States And Political Subdivisions;
0001140361-25-018588 20241231 Available For Sale Securities Debt Securities 160261000.0000 USD 0 us-gaap/2024 Financial Instrument= Corporate Debt Securities;
0001140361-25-018588 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 28301000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 35570000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20240331 Commissions And Underwriting Expenses -2187000.0000 USD 1 0001140361-25-018588 Consolidation Items= Corporate Non Segment;
0001140361-25-018588 20250331 Commissions And Underwriting Expenses 11680000.0000 USD 1 0001140361-25-018588
0001140361-25-018588 20231231 Common Stock Shares Outstanding 20402288.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001140361-25-018588 20240331 Common Stock Shares Outstanding 20399758.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001140361-25-018588 20250331 Common Stock Value 22401000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20250331 Comprehensive Income Net Of Tax 3280000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20241231 Debt Securities Available For Sale Allowance For Credit Loss 0.0000 USD 0 us-gaap/2024 Financial Instrument= Debt Securities;
0001140361-25-018588 20250331 Debt Securities Available For Sale Allowance For Credit Loss 0.0000 USD 0 us-gaap/2024 Financial Instrument= Corporate Debt Securities;
0001140361-25-018588 20250331 Deferred Compensation Equity 0.0000 USD 0 us-gaap/2024
0001140361-25-018588 20250331 Equity Securities Fv Ni Cost 4943000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20250331 Equity Securities Fv Ni Current And Noncurrent 8671000.0000 USD 0 us-gaap/2024 Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001140361-25-018588 20250331 Equity Securities Fv Ni Unrealized Gain Loss 767000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Adjustments Related To Tax Withholding For Share Based Compensation 4000.0000 USD 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0001140361-25-018588 20250331 Assets 139965000.0000 USD 0 us-gaap/2024 Business Segments= American Southern; Consolidation Items= Operating Segments;
0001140361-25-018588 20250331 Assets 32650000.0000 USD 0 us-gaap/2024 Consolidation Items= Corporate Non Segment;
0001140361-25-018588 20241231 Available For Sale Debt Securities Amortized Cost Basis 24730000.0000 USD 0 us-gaap/2024 Financial Instrument= Asset Backed Securities;
0001140361-25-018588 20250331 Available For Sale Debt Securities Amortized Cost Basis 37864000.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Industrial Sector; Financial Instrument= Corporate Debt Securities;
0001140361-25-018588 20250331 Available For Sale Debt Securities Amortized Cost Basis 24386000.0000 USD 0 us-gaap/2024 Financial Instrument= Asset Backed Securities;
0001140361-25-018588 20241231 Available For Sale Securities Debt Securities 41957000.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Commercial Sector; Financial Instrument= Corporate Debt Securities;
0001140361-25-018588 20241231 Available For Sale Securities Debt Securities 34117000.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Industrial Sector; Financial Instrument= Corporate Debt Securities;
0001140361-25-018588 20241231 Available For Sale Securities Debt Securities 187000.0000 USD 0 us-gaap/2024 Financial Instrument= Redeemable Preferred Stock;
0001140361-25-018588 20241231 Available For Sale Securities Debt Securities 7623000.0000 USD 0 us-gaap/2024 Financial Instrument= U S States And Political Subdivisions;
0001140361-25-018588 20250331 Available For Sale Securities Debt Securities 25142000.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Technology Sector; Financial Instrument= Corporate Debt Securities;
0001140361-25-018588 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 21189000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20241231 Common Stock Shares Issued 22400894.0000 shares 0 us-gaap/2024
0001140361-25-018588 20241231 Common Stock Shares Outstanding 20399758.0000 shares 0 us-gaap/2024
0001140361-25-018588 20241231 Debt Securities Available For Sale Allowance For Credit Loss 0.0000 USD 0 us-gaap/2024 Financial Instrument= Redeemable Preferred Stock;
0001140361-25-018588 20240331 Depreciation Amortization And Accretion Net 113000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20240331 Dividends Preferred Stock 99000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001140361-25-018588 20250331 Payments Related To Tax Withholding For Share Based Compensation 4000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20240331 Policyholder Benefits And Claims Incurred Net 0.0000 USD 1 us-gaap/2024 Consolidation Items= Corporate Non Segment;
0001140361-25-018588 20250331 Earnings Per Share Basic 0.0300 USD 1 us-gaap/2024
0001140361-25-018588 20241231 Equity Securities Fv Ni Current And Noncurrent 6751000.0000 USD 0 us-gaap/2024 Equity Securities By Industry= Communications; Financial Instrument= Common Stock And Nonredeemable Preferred Stock;
0001140361-25-018588 20241231 Equity Securities Fv Ni Current And Noncurrent 189000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001140361-25-018588 20240331 Income Loss From Equity Method Investments -103000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Income Taxes Paid 315000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20241231 Intangible Assets Net Including Goodwill 2544000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20240331 Interest Paid Net 856000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Interest Paid Net 788000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Investments 232521000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20250331 Liability For Future Policy Benefits 100036000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20250331 Loans Insurance Policy 1670000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20241231 Long Term Line Of Credit 4023000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20240331 Net Cash Provided By Used In Operating Activities -5319000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20240331 Net Investment Income 2556000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20240331 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax -2488000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax 659000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Other Expenses 4723000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20240331 Other Income 3000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20241231 Preferred Stock Shares Authorized 4000000.0000 shares 0 us-gaap/2024
0001140361-25-018588 20250331 Preferred Stock Shares Outstanding 55000.0000 shares 0 us-gaap/2024
0001140361-25-018588 20240331 Premiums Receivable Allowance For Doubtful Accounts 216000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20240331 Reinsurance Recoverables Allowance 56000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20240331 Revenues 46997000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20240331 Stockholders Equity 64200000.0000 USD 0 us-gaap/2024 Credit Facility= Revolving Credit Facility; Debt Instrument= Credit Agreement First Amendment; Range= Minimum;
0001140361-25-018588 20241231 Stockholders Equity -7408000.0000 USD 0 us-gaap/2024 Equity Components= Treasury Stock Common;
0001140361-25-018588 20250331 Stockholders Equity -16234000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001140361-25-018588 20250331 Stockholders Equity 0.0000 USD 0 us-gaap/2024 Equity Components= Deferred Compensation Share Based Payments;
0001140361-25-018588 20250331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -2087000.0000 USD 1 us-gaap/2024 Consolidation Items= Corporate Non Segment;
0001140361-25-018588 20240331 Income Tax Expense Benefit -508000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20240331 Interest Expense 855000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20250331 Liabilities 286051000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20241231 Liabilities And Stockholders Equity 393428000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20231231 Liability For Claims And Claims Adjustment Expense 87478000.0000 USD 0 us-gaap/2024
0001140361-25-018588 20240331 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax -522000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20241231 Other Invested Assets Cost 7946000.0000 USD 0 0001140361-25-018588
0001140361-25-018588 20240331 Payments Related To Tax Withholding For Share Based Compensation 7000.0000 USD 1 us-gaap/2024
0001140361-25-018588 20241231 Preferred Stock Par Or Stated Value Per Share 1.0000 USD 0 us-gaap/2024
0001140361-25-018588 20240331 Shares Paid For Tax Withholding For Share Based Compensation 2530.0000 shares 1 us-gaap/2024 Equity Components= Common Stock;
0001140361-25-018588 20231231 Stockholders Equity 57425000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001140361-25-018588 20240331 Stockholders Equity 57425000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001140361-25-018588 20241231 Stockholders Equity 57425000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001140361-25-018588 20241231 Stockholders Equity 45854000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001140361-25-018588 20250331 Stockholders Equity 55000.0000 USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0001140361-25-018588 20250331 Treasury Stock Common Value 7412000.0000 USD 0 us-gaap/2024

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
ddate The end date for the data value, rounded to the nearest month end.
qtrs The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value.
uom The unit of measure for the value.
segments Tags used to represent axis and member reporting.
coreg If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity.
value The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point.
footnote The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank.

Tags

tag version custom abstract datatype iord crdr tlabel doc
Other Policyholder Funds us-gaap/2024 0 0 monetary I C Other Policyholder Funds Amount due to policyholders for funds held that are returnable under the terms of insurance contracts, classified as other.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 0 0 monetary I D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Debt Securities Available For Sale Allowance For Credit Loss us-gaap/2024 0 0 monetary I C Debt Securities, Available-for-Sale, Allowance for Credit Loss Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Accounts Payable And Accrued Liabilities Current And Noncurrent us-gaap/2024 0 0 monetary I C Accounts Payable and Accrued Liabilities Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.
Payments To Acquire Property Plant And Equipment us-gaap/2024 0 0 monetary D C Payments to Acquire Property, Plant, and Equipment The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Comprehensive Income Net Of Tax us-gaap/2024 0 0 monetary D C Comprehensive Income (Loss), Net of Tax, Attributable to Parent Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Deferred Policy Acquisition Costs us-gaap/2024 0 0 monetary I D Deferred Policy Acquisition Cost Amount of deferred policy acquisition cost capitalized on contract remaining in force.
Equity Securities Fv Ni Current And Noncurrent us-gaap/2024 0 0 monetary I D Equity Securities, FV-NI Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).
Equity Securities Fv Ni Unrealized Gain Loss us-gaap/2024 0 0 monetary D C Equity Securities, FV-NI, Unrealized Gain (Loss) Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 0 0 monetary D C Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Liabilities us-gaap/2024 0 0 monetary I C Liabilities Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.
Liabilities And Stockholders Equity us-gaap/2024 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Liability For Future Policy Benefits us-gaap/2024 0 0 monetary I C Liability for Future Policy Benefit, before Reinsurance Amount, before effect of reinsurance, of present value of future benefit to be paid to or on behalf of policyholder and related expense less present value of future net premium receivable under insurance contract.
Loans Insurance Policy us-gaap/2024 0 0 monetary I D Loans, Gross, Insurance Policy Amount before allowance of loans made to policy and contract holders using their life insurance contracts' cash value or separate accounts as collateral. Includes deferred interest and fees, undisbursed portion of loan balance, unamortized costs and premiums over and discounts from face amounts. Excludes loans and leases covered under loss sharing agreements.
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax us-gaap/2024 0 0 monetary D C OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax us-gaap/2024 0 0 monetary D C OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.
Other Income us-gaap/2024 0 0 monetary D C Other Income Amount of revenue and income classified as other.
Reinsurance Recoverables Allowance us-gaap/2024 0 0 monetary I C Reinsurance Recoverable, Allowance for Credit Loss Amount of allowance for credit loss on reinsurance recoverable.
Retained Earnings Accumulated Deficit us-gaap/2024 0 0 monetary I C Retained Earnings (Accumulated Deficit) Amount of accumulated undistributed earnings (deficit).
Payments To Acquire Investments us-gaap/2024 0 0 monetary D C Payments to Acquire Investments The cash outflow associated with the purchase of all investments (debt, security, other) during the period.
Additional Paid In Capital us-gaap/2024 0 0 monetary I C Additional Paid in Capital Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.
Adjustments Related To Tax Withholding For Share Based Compensation us-gaap/2024 0 0 monetary D D Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.
Available For Sale Securities Debt Securities us-gaap/2024 0 0 monetary I D Debt Securities, Available-for-Sale Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Common Stock Dividends Per Share Declared us-gaap/2024 0 0 perShare D Common Stock, Dividends, Per Share, Declared Aggregate dividends declared during the period for each share of common stock outstanding.
Common Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock.
Common Stock Shares Outstanding us-gaap/2024 0 0 shares I Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Income Tax Expense Benefit us-gaap/2024 0 0 monetary D D Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Increase Decrease In Receivables us-gaap/2024 0 0 monetary D C Increase (Decrease) in Receivables The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.
Intangible Assets Net Including Goodwill us-gaap/2024 0 0 monetary I D Intangible Assets, Net (Including Goodwill) Amount, after impairment and amortization, of goodwill, indefinite-lived, and finite-lived intangible assets.
Net Income Loss us-gaap/2024 0 0 monetary D C Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Preferred Stock Redemption Amount us-gaap/2024 0 0 monetary I C Preferred Stock, Redemption Amount The redemption (or callable) amount of currently redeemable preferred stock. Includes amounts representing dividends not currently declared or paid but which will be payable under the redemption features or for which ultimate payment is solely within the control of the issuer.
Stockholders Equity us-gaap/2024 0 0 monetary I C Equity, Attributable to Parent Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
Policyholder Benefits And Claims Incurred Net us-gaap/2024 0 0 monetary D D Policyholder Benefits and Claims Incurred, Net Amount, after effects of policies assumed or ceded, of expense related to the provision for policy benefits and costs incurred.
Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 0 0 monetary I C Accumulated Other Comprehensive Income (Loss), Net of Tax Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.
Allocated Share Based Compensation Expense us-gaap/2024 0 0 monetary D D Share-Based Payment Arrangement, Expense Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Assets us-gaap/2024 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Common Stock Shares Issued us-gaap/2024 0 0 shares I Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Depreciation Amortization And Accretion Net us-gaap/2024 0 0 monetary D D Depreciation, Amortization and Accretion, Net The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.
Earnings Per Share Diluted us-gaap/2024 0 0 perShare D Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Equity Securities Fv Ni Cost us-gaap/2024 0 0 monetary I D Equity Securities, FV-NI, Cost Cost of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Excludes equity method investment and investment in equity security without readily determinable fair value.
Income Taxes Paid us-gaap/2024 0 0 monetary D C Income Taxes Paid Amount, before refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.
Premiums And Other Receivables Net us-gaap/2024 0 0 monetary I D Premiums and Other Receivables, Net Carrying amount as of the balance sheet date, net of allowance for doubtful accounts, of all premiums and other types of receivables due from other persons or entities.
Provision For Loan Lease And Other Losses us-gaap/2024 0 0 monetary D D Provision for Loan, Lease, and Other Losses Amount of expense related loan transactions, lease transactions, credit loss from transactions other than loan and lease transactions, and other loss based on assessment of uncollectability from the counterparty to reduce the account to their net realizable value.
Unearned Premiums us-gaap/2024 0 0 monetary I C Unearned Premiums Carrying amount of premiums written on insurance contracts that have not been earned as of the balance sheet date.
Commissions And Underwriting Expenses 0001140361-25-018588 1 0 monetary D D Commissions And Underwriting Expenses This element represents the direct and indirect costs incurred during the period related to the acquisition or renewal of insurance contracts and other operating costs and expense items associated with the entity's normal revenue producing operation.
Interest Expense us-gaap/2024 0 0 monetary D D Interest Expense, Operating and Nonoperating Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense.
Dividends Common Stock us-gaap/2024 0 0 monetary D D Dividends, Common Stock Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).
Increase Decrease In Other Operating Assets us-gaap/2024 0 0 monetary D C Increase (Decrease) in Other Operating Assets Amount of increase (decrease) in operating assets classified as other.
Other Expenses us-gaap/2024 0 0 monetary D D Other Expenses Amount of expense classified as other.
Preferred Stock Shares Issued us-gaap/2024 0 0 shares I Preferred Stock, Shares Issued Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.
Proceeds From Sale Of Marketable Securities And Policy Loans 0001140361-25-018588 1 0 monetary D D Proceeds From Sale Of Marketable Securities and Policy Loans The cash inflow associated with the aggregate amount received by the entity through the sale of marketable securities and policy loans during the period.
Benefits Losses And Expenses us-gaap/2024 0 0 monetary D D Benefits, Losses and Expenses The total amount of expense recognized during the period for future policy benefits, claims and claims adjustment costs, and for selling, general and administrative costs.
Cash And Cash Equivalents At Carrying Value us-gaap/2024 0 0 monetary I D Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Equity Method Investments us-gaap/2024 0 0 monetary I D Equity Method Investments This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.
Long Term Line Of Credit us-gaap/2024 0 0 monetary I C Long-Term Line of Credit, Noncurrent The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.
Preferred Stock Value us-gaap/2024 0 0 monetary I C Preferred Stock, Value, Issued Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
Premiums Earned Net us-gaap/2024 0 0 monetary D C Premiums Earned, Net Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.
Real Estate Investments us-gaap/2024 0 0 monetary I D Real Estate Investments, Net Amount of real estate investments, net of accumulated depreciation, which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; (7) other real estate investments; (8) real estate joint ventures; and (9) unconsolidated real estate and other joint ventures not separately presented.
Amortization Of Restricted Stock 0001140361-25-018588 1 0 monetary D C Amortization of Restricted Stock Represents the equity impact recognized during the period arising from the amortization of unearned stock grant compensation.
Deferred Income Tax Assets Net Without Jurisdictional Netting 0001140361-25-018588 1 0 monetary I D Deferred Income Tax Assets, Net, Without Jurisdictional Netting Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.
Proceeds From Maturity Prepayments And Calls Of Available For Sale Fixed Maturity Securities 0001140361-25-018588 1 0 monetary D D Proceeds from Maturity Prepayments and Calls of Available-for-sale Fixed Maturity Securities The cash inflow from maturity, prepayment and call of investment in fixed maturity security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense And Other Policyholder Funds 0001140361-25-018588 1 0 monetary I C Liability for Future Policy Benefits and Unpaid Claims and Claims Adjustment Expense and Other Policyholder Funds This element includes the aggregate amount of policy reserves (provided for future obligations including unpaid claims and claims adjustment expenses) and policy benefits (liability for future policy benefits) as of the balance sheet dates; and unearned premiums and other policy liabilities.
Available For Sale Debt Securities Amortized Cost Basis us-gaap/2024 0 0 monetary I D Debt Securities, Available-for-Sale, Amortized Cost Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Deferred Compensation Equity us-gaap/2024 0 0 monetary I D Deferred Compensation Equity Value of stock issued under share-based plans to employees or officers which is the unearned portion, accounted for under the fair value method.
Deferred Income Tax Expense Benefit us-gaap/2024 0 0 monetary D D Deferred Income Tax Expense (Benefit) Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Deferred Policy Acquisition Cost Amortization Expense us-gaap/2024 0 0 monetary D D Deferred Policy Acquisition Costs, Amortization Expense Amount of amortization expense (reversal of expense) for deferred policy acquisition costs.
Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust us-gaap/2024 0 0 monetary I C Junior Subordinated Debenture Owed to Unconsolidated Subsidiary Trust Including the current and noncurrent portions, the carrying value of junior subordinated long-term debt owed to unconsolidated subsidiary trusts as of the balance sheet date. Such debt places a lender in a lien position behind debt having a higher priority of repayment in liquidation of the entity's assets and was initially scheduled to be repaid after one year or beyond the normal operating cycle if longer.
Liability For Claims And Claims Adjustment Expense us-gaap/2024 0 0 monetary I C Liability for Claims and Claims Adjustment Expense The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.
Net Cash Provided By Used In Operating Activities us-gaap/2024 0 0 monetary D Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect us-gaap/2024 0 0 monetary D D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Common Stock Value us-gaap/2024 0 0 monetary I C Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Income Loss From Equity Method Investments us-gaap/2024 0 0 monetary D C Income (Loss) from Equity Method Investments Amount of income (loss) for proportionate share of equity method investee's income (loss).
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent us-gaap/2024 0 0 monetary D C Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Amount after tax of other comprehensive income (loss) attributable to parent entity.
Revenues us-gaap/2024 0 0 monetary D C Revenues Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Other Invested Assets Cost 0001140361-25-018588 1 0 monetary I D Other Invested Assets, Cost Amount of investments classified as other at cost.
Commitments And Contingencies us-gaap/2024 0 0 monetary I C Commitments and Contingencies Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
Common Stock Shares Authorized us-gaap/2024 0 0 shares I Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Dividends Preferred Stock us-gaap/2024 0 0 monetary D D Dividends, Preferred Stock Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).
Increase Decrease In Insurance Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Insurance Liabilities The increase (decrease) in insurance liability balances during the period.
Interest Paid Net us-gaap/2024 0 0 monetary D C Interest Paid, Excluding Capitalized Interest, Operating Activities Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Net Cash Provided By Used In Financing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Net Income Loss Available To Common Stockholders Basic us-gaap/2024 0 0 monetary D C Net Income (Loss) Available to Common Stockholders, Basic Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.
Payments Related To Tax Withholding For Share Based Compensation us-gaap/2024 0 0 monetary D C Payment, Tax Withholding, Share-Based Payment Arrangement Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.
Preferred Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Preferred Stock, Par or Stated Value Per Share Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
Premiums Receivable Allowance For Doubtful Accounts us-gaap/2024 0 0 monetary I C Premium Receivable, Allowance for Credit Loss The carrying value as of the balance sheet date of the estimated valuation allowance to reduce gross premiums receivable to net realizable value.
Proceeds From Lines Of Credit us-gaap/2024 0 0 monetary D D Proceeds from Lines of Credit Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.
Shares Paid For Tax Withholding For Share Based Compensation us-gaap/2024 0 0 shares D Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.
Earnings Per Share Basic us-gaap/2024 0 0 perShare D Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Increase Decrease In Accounts Payable And Accrued Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Accounts Payable and Accrued Liabilities The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.
Preferred Stock Dividends Income Statement Impact us-gaap/2024 0 0 monetary D D Preferred Stock Dividends, Income Statement Impact The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.
Net Cash Provided By Used In Investing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Net Investment Income us-gaap/2024 0 0 monetary D C Net Investment Income Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.
Other Investments us-gaap/2024 0 0 monetary I D Other Investments Amount of investments classified as other.
Preferred Stock Shares Authorized us-gaap/2024 0 0 shares I Preferred Stock, Shares Authorized The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Preferred Stock Shares Outstanding us-gaap/2024 0 0 shares I Preferred Stock, Shares Outstanding Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
Reinsurance Recoverables On Paid And Unpaid Losses us-gaap/2024 0 0 monetary I D Reinsurance Recoverable for Paid and Unpaid Claims and Claims Adjustments Amount, after valuation allowance, recoverable under reinsurance contracts. Examples include, but are not limited to, settled and unsettled claims, incurred but not reported losses, loss adjustment expense, policy benefits and policy reserves. Excludes premiums paid under reinsurance contracts.
Treasury Stock Common Value us-gaap/2024 0 0 monetary I D Treasury Stock, Common, Value Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.
Investments us-gaap/2024 0 0 monetary I D Investments Sum of the carrying amounts as of the balance sheet date of all investments.
Other Assets us-gaap/2024 0 0 monetary I D Other Assets Amount of assets classified as other.
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax us-gaap/2024 0 0 monetary D D OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.
Treasury Stock Common Shares us-gaap/2024 0 0 shares I Treasury Stock, Common, Shares Number of previously issued common shares repurchased by the issuing entity and held in treasury.

Description
Field Name Field Description
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
custom 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns.
abstract 1 if the tag is not used to represent a numeric fact.
datatype If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag.
iord If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration.
crdr If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL.
tlabel If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here.
doc The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL.

Presentation of Statements

adsh report line stmt inpth rfile tag version plabel negating
0001140361-25-018588 3 5 BS 1 H Equity Securities Fv Ni Cost us-gaap/2024 Equity securities, cost 0
0001140361-25-018588 3 6 BS 1 H Other Invested Assets Cost 0001140361-25-018588 Other invested assets, cost 0
0001140361-25-018588 3 8 BS 1 H Reinsurance Recoverables Allowance us-gaap/2024 Reinsurance, allowance for expected credit losses 0
0001140361-25-018588 3 9 BS 1 H Premiums Receivable Allowance For Doubtful Accounts us-gaap/2024 Insurance premiums and other, allowance for expected credit losses 0
0001140361-25-018588 3 12 BS 1 H Preferred Stock Par Or Stated Value Per Share us-gaap/2024 Preferred stock, par value (in dollars per share) 0
0001140361-25-018588 3 13 BS 1 H Preferred Stock Shares Authorized us-gaap/2024 Preferred stock, shares authorized (in shares) 0
0001140361-25-018588 3 14 BS 1 H Preferred Stock Shares Issued us-gaap/2024 Preferred stock, shares issued (in shares) 0
0001140361-25-018588 3 15 BS 1 H Preferred Stock Shares Outstanding us-gaap/2024 Preferred stock, shares outstanding (in shares) 0
0001140361-25-018588 3 16 BS 1 H Preferred Stock Redemption Amount us-gaap/2024 Preferred stock, redemption value 0
0001140361-25-018588 3 17 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2024 Common stock, par value (in dollars per share) 0
0001140361-25-018588 3 18 BS 1 H Common Stock Shares Authorized us-gaap/2024 Common stock, shares authorized (in shares) 0
0001140361-25-018588 3 19 BS 1 H Common Stock Shares Issued us-gaap/2024 Common stock, shares issued (in shares) 0
0001140361-25-018588 3 20 BS 1 H Common Stock Shares Outstanding us-gaap/2024 Common stock, shares outstanding (in shares) 0
0001140361-25-018588 3 21 BS 1 H Treasury Stock Common Shares us-gaap/2024 Treasury stock, at cost (in shares) 0
0001140361-25-018588 4 2 IS 0 H Premiums Earned Net us-gaap/2024 Insurance premiums, net 0
0001140361-25-018588 4 3 IS 0 H Net Investment Income us-gaap/2024 Net investment income 0
0001140361-25-018588 4 4 IS 0 H Equity Securities Fv Ni Unrealized Gain Loss us-gaap/2024 Unrealized gains (losses) on equity securities, net 0
0001140361-25-018588 4 5 IS 0 H Other Income us-gaap/2024 Other income 0
0001140361-25-018588 4 6 IS 0 H Revenues us-gaap/2024 Total revenue 0
0001140361-25-018588 4 8 IS 0 H Policyholder Benefits And Claims Incurred Net us-gaap/2024 Insurance benefits and losses incurred 0
0001140361-25-018588 4 9 IS 0 H Commissions And Underwriting Expenses 0001140361-25-018588 Commissions and underwriting expenses 0
0001140361-25-018588 4 10 IS 0 H Interest Expense us-gaap/2024 Interest expense 0
0001140361-25-018588 4 11 IS 0 H Other Expenses us-gaap/2024 Other expense 0
0001140361-25-018588 4 12 IS 0 H Benefits Losses And Expenses us-gaap/2024 Total benefits and expenses 0
0001140361-25-018588 4 13 IS 0 H Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 Income (loss) before income taxes 0
0001140361-25-018588 4 14 IS 0 H Income Tax Expense Benefit us-gaap/2024 Income tax expense (benefit) 0
0001140361-25-018588 4 15 IS 0 H Net Income Loss us-gaap/2024 Net income (loss) 0
0001140361-25-018588 4 16 IS 0 H Preferred Stock Dividends Income Statement Impact us-gaap/2024 Preferred stock dividends 1
0001140361-25-018588 4 17 IS 0 H Net Income Loss Available To Common Stockholders Basic us-gaap/2024 Net income (loss) applicable to common shareholders 0
0001140361-25-018588 4 18 IS 0 H Earnings Per Share Basic us-gaap/2024 Earnings (loss) per common share (basic) (in dollars per share) 0
0001140361-25-018588 4 19 IS 0 H Earnings Per Share Diluted us-gaap/2024 Earnings (loss) per common share (diluted) (in dollars per share) 0
0001140361-25-018588 5 1 CI 0 H Net Income Loss us-gaap/2024 Net income (loss) 0
0001140361-25-018588 5 4 CI 0 H Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax us-gaap/2024 Gross unrealized holding gains (losses) arising in the period 0
0001140361-25-018588 5 5 CI 0 H Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax us-gaap/2024 Related income tax effect 1
0001140361-25-018588 5 6 CI 0 H Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax us-gaap/2024 Subtotal 0
0001140361-25-018588 3 4 BS 1 H Debt Securities Available For Sale Allowance For Credit Loss us-gaap/2024 Allowance for credit losses 0
0001140361-25-018588 5 7 CI 0 H Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent us-gaap/2024 Total other comprehensive income (loss), net of tax 0
0001140361-25-018588 5 8 CI 0 H Comprehensive Income Net Of Tax us-gaap/2024 Total comprehensive income (loss) 0
0001140361-25-018588 6 13 EQ 0 H Stockholders Equity us-gaap/2024 Balance, beginning of period 0
0001140361-25-018588 2 2 BS 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2024 Cash and cash equivalents 0
0001140361-25-018588 2 4 BS 0 H Available For Sale Securities Debt Securities us-gaap/2024 Fixed maturities, available-for-sale, at fair value (amortized cost: $234,993 and $236,299; no allowance for credit losses) 0
0001140361-25-018588 2 5 BS 0 H Equity Securities Fv Ni Current And Noncurrent us-gaap/2024 Equity securities, at fair value (cost: $4,943 and $4,939) 0
0001140361-25-018588 2 6 BS 0 H Other Investments us-gaap/2024 Other invested assets (cost: $7,946 and $7,946) 0
0001140361-25-018588 2 7 BS 0 H Loans Insurance Policy us-gaap/2024 Policy loans 0
0001140361-25-018588 2 8 BS 0 H Real Estate Investments us-gaap/2024 Real estate 0
0001140361-25-018588 2 9 BS 0 H Equity Method Investments us-gaap/2024 Investment in unconsolidated trusts 0
0001140361-25-018588 2 10 BS 0 H Investments us-gaap/2024 Total investments 0
0001140361-25-018588 2 12 BS 0 H Reinsurance Recoverables On Paid And Unpaid Losses us-gaap/2024 Reinsurance (net of allowance for expected credit losses of $45 and $51) 0
0001140361-25-018588 2 13 BS 0 H Premiums And Other Receivables Net us-gaap/2024 Insurance premiums and other (net of allowance for expected credit losses $195 and $201) 0
0001140361-25-018588 2 14 BS 0 H Deferred Income Tax Assets Net Without Jurisdictional Netting 0001140361-25-018588 Deferred income taxes, net 0
0001140361-25-018588 2 15 BS 0 H Deferred Policy Acquisition Costs us-gaap/2024 Deferred acquisition costs 0
0001140361-25-018588 2 16 BS 0 H Other Assets us-gaap/2024 Other assets 0
0001140361-25-018588 2 17 BS 0 H Intangible Assets Net Including Goodwill us-gaap/2024 Intangibles 0
0001140361-25-018588 2 18 BS 0 H Assets us-gaap/2024 Total assets 0
0001140361-25-018588 2 21 BS 0 H Liability For Future Policy Benefits us-gaap/2024 Future policy benefits 0
0001140361-25-018588 2 22 BS 0 H Unearned Premiums us-gaap/2024 Unearned premiums 0
0001140361-25-018588 2 23 BS 0 H Liability For Claims And Claims Adjustment Expense us-gaap/2024 Losses and claims 0
0001140361-25-018588 2 24 BS 0 H Other Policyholder Funds us-gaap/2024 Other policy liabilities 0
0001140361-25-018588 2 25 BS 0 H Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense And Other Policyholder Funds 0001140361-25-018588 Total insurance reserves and policyholder funds 0
0001140361-25-018588 2 26 BS 0 H Accounts Payable And Accrued Liabilities Current And Noncurrent us-gaap/2024 Accounts payable and accrued expenses 0
0001140361-25-018588 2 27 BS 0 H Long Term Line Of Credit us-gaap/2024 Revolving credit facility 0
0001140361-25-018588 2 28 BS 0 H Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust us-gaap/2024 Junior subordinated debenture obligations, net 0
0001140361-25-018588 2 29 BS 0 H Liabilities us-gaap/2024 Total liabilities 0
0001140361-25-018588 2 30 BS 0 H Commitments And Contingencies us-gaap/2024 Commitments and contingencies (Notes 3 and 12) 0
0001140361-25-018588 2 32 BS 0 H Preferred Stock Value us-gaap/2024 Preferred stock, $1 par, 4,000,000 shares authorized; Series D preferred, 55,000 shares issued and outstanding; $5,500 redemption value 0
0001140361-25-018588 2 33 BS 0 H Common Stock Value us-gaap/2024 Common stock, $1 par, 50,000,000 shares authorized; shares issued: 22,400,894; shares outstanding: 20,397,228 and 20,399,758 0
0001140361-25-018588 2 34 BS 0 H Additional Paid In Capital us-gaap/2024 Additional paid-in capital 0
0001140361-25-018588 2 35 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Retained earnings 0
0001140361-25-018588 2 36 BS 0 H Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Accumulated other comprehensive loss 0
0001140361-25-018588 2 37 BS 0 H Deferred Compensation Equity us-gaap/2024 Unearned stock grant compensation 1
0001140361-25-018588 2 38 BS 0 H Treasury Stock Common Value us-gaap/2024 Treasury stock, at cost: 2,003,666 and 2,001,136 shares 1
0001140361-25-018588 2 39 BS 0 H Stockholders Equity us-gaap/2024 Total shareholders' equity 0
0001140361-25-018588 2 40 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 Total liabilities and shareholders' equity 0
0001140361-25-018588 3 3 BS 1 H Available For Sale Debt Securities Amortized Cost Basis us-gaap/2024 Fixed maturities, cost 0
0001140361-25-018588 6 14 EQ 0 H Net Income Loss us-gaap/2024 Net income (loss) 0
0001140361-25-018588 6 15 EQ 0 H Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent us-gaap/2024 Other comprehensive income (loss), net of tax 0
0001140361-25-018588 6 16 EQ 0 H Dividends Common Stock us-gaap/2024 Dividends on common stock 1
0001140361-25-018588 6 17 EQ 0 H Dividends Preferred Stock us-gaap/2024 Dividends accrued on preferred stock 1
0001140361-25-018588 6 18 EQ 0 H Amortization Of Restricted Stock 0001140361-25-018588 Amortization of unearned compensation 0
0001140361-25-018588 6 19 EQ 0 H Adjustments Related To Tax Withholding For Share Based Compensation us-gaap/2024 Net shares acquired related to employee share-based compensation plans 1
0001140361-25-018588 6 20 EQ 0 H Stockholders Equity us-gaap/2024 Balance, end of period 0
0001140361-25-018588 6 21 EQ 0 H Common Stock Dividends Per Share Declared us-gaap/2024 Dividends declared on common stock per share (in dollars per share) 0
0001140361-25-018588 6 22 EQ 0 H Common Stock Shares Outstanding us-gaap/2024 Balance, beginning of period (in shares) 0
0001140361-25-018588 6 23 EQ 0 H Shares Paid For Tax Withholding For Share Based Compensation us-gaap/2024 Net shares acquired under employee share-based compensation plans (in shares) 1
0001140361-25-018588 6 24 EQ 0 H Common Stock Shares Outstanding us-gaap/2024 Balance, end of period (in shares) 0
0001140361-25-018588 7 2 CF 0 H Net Income Loss us-gaap/2024 Net income (loss) 0
0001140361-25-018588 7 4 CF 0 H Deferred Policy Acquisition Cost Amortization Expense us-gaap/2024 Amortization of acquisition costs, net 0
0001140361-25-018588 7 5 CF 0 H Equity Securities Fv Ni Unrealized Gain Loss us-gaap/2024 Unrealized (gains) losses on equity securities 1
0001140361-25-018588 7 6 CF 0 H Income Loss From Equity Method Investments us-gaap/2024 Losses from equity method investees 1
0001140361-25-018588 7 7 CF 0 H Allocated Share Based Compensation Expense us-gaap/2024 Compensation expense related to share awards 0
0001140361-25-018588 7 8 CF 0 H Provision For Loan Lease And Other Losses us-gaap/2024 Benefit for credit losses 0
0001140361-25-018588 7 9 CF 0 H Depreciation Amortization And Accretion Net us-gaap/2024 Depreciation and amortization 0
0001140361-25-018588 7 10 CF 0 H Deferred Income Tax Expense Benefit us-gaap/2024 Deferred income tax expense (benefit) 0
0001140361-25-018588 7 11 CF 0 H Increase Decrease In Receivables us-gaap/2024 Decrease in receivables, net 1
0001140361-25-018588 7 12 CF 0 H Increase Decrease In Insurance Liabilities us-gaap/2024 Decrease in insurance reserves and policyholder funds 0
0001140361-25-018588 7 13 CF 0 H Increase Decrease In Accounts Payable And Accrued Liabilities us-gaap/2024 Decrease in accounts payable and accrued expenses 0
0001140361-25-018588 7 14 CF 0 H Increase Decrease In Other Operating Assets us-gaap/2024 Other, net 1
0001140361-25-018588 7 15 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Net cash used in operating activities 0
0001140361-25-018588 7 17 CF 0 H Proceeds From Sale Of Marketable Securities And Policy Loans 0001140361-25-018588 Proceeds from investments sold 0
0001140361-25-018588 7 18 CF 0 H Proceeds From Maturity Prepayments And Calls Of Available For Sale Fixed Maturity Securities 0001140361-25-018588 Proceeds from investments matured, called or redeemed 0
0001140361-25-018588 7 19 CF 0 H Payments To Acquire Investments us-gaap/2024 Investments purchased 1
0001140361-25-018588 7 20 CF 0 H Payments To Acquire Property Plant And Equipment us-gaap/2024 Additions to property and equipment 1
0001140361-25-018588 7 21 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2024 Net cash provided by (used in) investing activities 0
0001140361-25-018588 7 23 CF 0 H Payments Related To Tax Withholding For Share Based Compensation us-gaap/2024 Treasury stock acquired - net employee share-based compensation 1
0001140361-25-018588 7 24 CF 0 H Proceeds From Lines Of Credit us-gaap/2024 Proceeds from revolving credit facility, net 0
0001140361-25-018588 7 25 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 Net cash (used in) provided by financing activities 0
0001140361-25-018588 7 26 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect us-gaap/2024 Net increase (decrease) in cash and cash equivalents 0
0001140361-25-018588 7 27 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents at beginning of period 0
0001140361-25-018588 7 28 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents at end of period 0
0001140361-25-018588 7 30 CF 0 H Interest Paid Net us-gaap/2024 Cash paid for interest 0
0001140361-25-018588 7 31 CF 0 H Income Taxes Paid us-gaap/2024 Cash paid for income taxes 0

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
report Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site.
line Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived.
stmt The financial statement location to which the value of the “report” field pertains.
inpth Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700.
rfile The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file.
tag The tag chosen by the filer for this line item.
version The taxonomy identifier if the tag is a standard tag, otherwise adsh.
plabel The text presented on the line item, also known as a “preferred” label.
negating Flag to indicate whether the plabel is negating.